Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Colorectal Neoplasms

Free Subscription Articles published in Int J Oncol Retrieve available abstracts of 45 articles: HTML format

Single Articles

June 2008
1. HIRO J , Inoue Y, Toiyama Y, Miki C, et al
   Mechanism of resistance to chemoradiation in p53 mutant human colon cancer.
   Int J Oncol. 2008;32:1305-10.
   PubMed     Related articles    Abstract available
   
   
   
2. MILICEVIC Z , Bogojevic D, Mihailovic M, Petrovic M, et al
   Molecular characterization of hsp90 isoforms in colorectal cancer cells and its association with tumour progression.
   Int J Oncol. 2008;32:1169-1178.
   PubMed     Related articles    Abstract available
   
   
   May 2008
3. TAKAGI K , Sowa Y, Cevik OM, Nakanishi R, et al
   CDK inhibitor enhances the sensitivity to 5-fluorouracil in colorectal cancer cells.
   Int J Oncol. 2008;32:1105-10.
   PubMed     Related articles    Abstract available
   
   
   
4. LUO X , Wang CZ, Chen J, Song WX, et al
   Characterization of gene expression regulated by American ginseng and ginsenoside Rg3 in human colorectal cancer cells.
   Int J Oncol. 2008;32:975-83.
   PubMed     Related articles    Abstract available
   
   
   April 2008
5. PANJIDEH H , Da Silva Coelho VC, Dernedde J, Bachran C, et al
   Biodistribution and efficacy of [131I]A33scFv::CDy, a recombinant antibody-enzyme protein for colon cancer.
   Int J Oncol. 2008;32:925-30.
   PubMed     Related articles    Abstract available
   
   
   
6. CAHLIN C , Lonnroth C, Arvidsson A, Nordgren S, et al
   Growth associated proteins in tumor cells and stroma related to disease progression of colon cancer accounting for tumor tissue PGE2 content.
   Int J Oncol. 2008;32:909-18.
   PubMed     Related articles    Abstract available
   
   
   
7. CEKANOVA M , Yuan JS, Li X, Kim K, et al
   Gene alterations by peroxisome proliferator-activated receptor gamma agonists in human colorectal cancer cells.
   Int J Oncol. 2008;32:809-19.
   PubMed     Related articles    Abstract available
   
   
   
8. MURATA T , Naomoto Y, Yamatsuji T, Okawa T, et al
   Localization of FAK is related with colorectal carcinogenesis.
   Int J Oncol. 2008;32:791-6.
   PubMed     Related articles    Abstract available
   
   
   March 2008
9. LEVY EM , Bianchini M, Von Euw EM, Barrio MM, et al
   Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.
   Int J Oncol. 2008;32:633-41.
   PubMed     Related articles    Abstract available
   
   
   
10. WIDJAJA E , Zheng W, Huang Z
    Classification of colonic tissues using near-infrared Raman spectroscopy and support vector machines.
    Int J Oncol. 2008;32:653-62.
    PubMed     Related articles    Abstract available
    
    
    
11. VANNUCCI L , Stepankova R, Kozakova H, Fiserova A, et al
    Colorectal carcinogenesis in germ-free and conventionally reared rats: different intestinal environments affect the systemic immunity.
    Int J Oncol. 2008;32:609-17.
    PubMed     Related articles    Abstract available
    
    
    
12. SIMIANTONAKI N , Jayasinghe C, Michel-Schmidt R, Peters K, et al
    Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
    Int J Oncol. 2008;32:585-92.
    PubMed     Related articles    Abstract available
    
    
    
13. SHINDOH N , Mori M, Terada Y, Oda K, et al
    YM753, a novel histone deacetylase inhibitor, exhibits antitumor activity with selective, sustained accumulation of acetylated histones in tumors in the WiDr xenograft model.
    Int J Oncol. 2008;32:545-55.
    PubMed     Related articles    Abstract available
    
    
    February 2008
14. KOMORI T , Takemasa I, Yamasaki M, Motoori M, et al
    Gene expression of colorectal cancer: Preoperative genetic diagnosis using endoscopic biopsies.
    Int J Oncol. 2008;32:367-75.
    PubMed     Related articles    Abstract available
    
    
    January 2008
15. HAMADA K , Monnai M, Kawai K, Nishime C, et al
    Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice.
    Int J Oncol. 2008;32:153-9.
    PubMed     Related articles    Abstract available
    
    
    December 2007
16. VAN SLAMBROUCK S , Grijelmo C, De Wever O, Bruyneel E, et al
    Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by alpha1-integrins during colon cancer cell invasion.
    Int J Oncol. 2007;31:1501-8.
    PubMed     Related articles    Abstract available
    
    
    
17. ADAMSEN BL , Kravik KL, Clausen OP, De Angelis PM, et al
    Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
    Int J Oncol. 2007;31:1491-500.
    PubMed     Related articles    Abstract available
    
    
    
18. ZOPF S , Neureiter D, Bouralexis S, Abt T, et al
    Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo.
    Int J Oncol. 2007;31:1391-402.
    PubMed     Related articles    Abstract available
    
    
    November 2007
19. WANG CZ , Xie JT, Zhang B, Ni M, et al
    Chemopreventive effects of Panax notoginseng and its major constituents on SW480 human colorectal cancer cells.
    Int J Oncol. 2007;31:1149-56.
    PubMed     Related articles    Abstract available
    
    
    
20. YOKOE T , Ohmachi T, Inoue H, Mimori K, et al
    Clinical significance of growth differentiation factor 11 in colorectal cancer.
    Int J Oncol. 2007;31:1097-101.
    PubMed     Related articles    Abstract available
    
    
    
21. YAJIMA S , Ishii M, Matsushita H, Aoyagi K, et al
    Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer.
    Int J Oncol. 2007;31:1029-37.
    PubMed     Related articles    Abstract available
    
    
    October 2007
22. COELHO V , Dernedde J, Petrausch U, Panjideh H, et al
    Design, construction, and in vitro analysis of A33scFv::CDy, a recombinant fusion protein for antibody-directed enzyme prodrug therapy in colon cancer.
    Int J Oncol. 2007;31:951-7.
    PubMed     Related articles    Abstract available
    
    
    
23. MATSUI TA , Sowa Y, Murata H, Takagi K, et al
    The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
    Int J Oncol. 2007;31:915-22.
    PubMed     Related articles    Abstract available
    
    
    
24. REES KA , Singh H, Brindle NP
    The receptor tyrosine kinase Tie1 is expressed and activated in epithelial tumour cell lines.
    Int J Oncol. 2007;31:893-7.
    PubMed     Related articles    Abstract available
    
    
    
25. GUDA K , Marino JN, Jung Y, Crary K, et al
    Strain-specific homeostatic responses during early stages of Azoxymethane-induced colon tumorigenesis in mice.
    Int J Oncol. 2007;31:837-42.
    PubMed     Related articles    Abstract available
    
    
    September 2007
26. FEDIER A , Dedes KJ, Imesch P, Von Bueren AO, et al
    The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Int J Oncol. 2007;31:633-41.
    PubMed     Related articles    Abstract available
    
    
    
27. KATAYAMA T , Nakanishi K, Nishihara H, Kamiyama N, et al
    Type I interferon prolongs cell cycle progression via p21WAF1/CIP1 induction in human colon cancer cells.
    Int J Oncol. 2007;31:613-20.
    PubMed     Related articles    Abstract available
    
    
    August 2007
28. VALLBOPHMER D , Yang DY, Kuramochi H, Shimizu D, et al
    DPD is a molecular determinant of capecitabine efficacy in colorectal cancer.
    Int J Oncol. 2007;31:413-8.
    PubMed     Related articles    Abstract available
    
    
    
29. KOSAKA Y , Mimori K, Tanaka F, Inoue H, et al
    Clinical significance of the loss of MATS1 mRNA expression in colorectal cancer.
    Int J Oncol. 2007;31:333-8.
    PubMed     Related articles    Abstract available
    
    
    
30. OGAWA M , Nakai S, Deguchi A, Nonomura T, et al
    Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells.
    Int J Oncol. 2007;31:323-31.
    PubMed     Related articles    Abstract available
    
    
    
31. SHNYDER SD , Cooper PA, Millington NJ, Pettit GR, et al
    Auristatin PYE, a novel synthetic derivative of dolastatin 10, is highly effective in human colon tumour models.
    Int J Oncol. 2007;31:353-60.
    PubMed     Related articles    Abstract available
    
    
    
32. SIMIANTONAKI N , Kurzik-Dumke U, Karyofylli G, Jayasinghe C, et al
    Loss of E-cadherin in the vicinity of necrosis in colorectal carcinomas: association with NFkappaB expression.
    Int J Oncol. 2007;31:269-75.
    PubMed     Related articles    Abstract available
    
    
    July 2007
33. DIMBERG J , Dienus O, Lofgren S, Hugander A, et al
    Expression and gene polymorphisms of the chemokine CXCL5 in colorectal cancer patients.
    Int J Oncol. 2007;31:97-102.
    PubMed     Related articles    Abstract available
    
    
    
34. BALDUS SE , Kort EJ, Schirmacher P, Dienes HP, et al
    Quantification of MET and hepatocyte growth factor/scatter factor expression in colorectal adenomas, carcinomas and non-neoplastic epithelia by quantitative laser scanning microscopy.
    Int J Oncol. 2007;31:199-204.
    PubMed     Related articles    Abstract available
    
    
    
35. LI JQ , Xu BJ, Shakhtour B, Deane N, et al
    Variability of in situ proteomic profiling and implications for study design in colorectal tumors.
    Int J Oncol. 2007;31:103-11.
    PubMed     Related articles    Abstract available
    
    
    
36. RAUL F , Gosse F, Osswald AB, Bouhadjar M, et al
    Follow-up of tumor development in the colons of living rats and implications for chemoprevention trials: assessment of aspirin-difluoromethylornithine combination.
    Int J Oncol. 2007;31:89-95.
    PubMed     Related articles    Abstract available
    
    
    June 2007
37. RAYBURN ER , Wang W, Zhang R, Wang H, et al
    Experimental therapy for colon cancer: Anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53.
    Int J Oncol. 2007;30:1511-9.
    PubMed     Related articles    Abstract available
    
    
    
38. NG CE , Liu QY, Qutob SS, Scott BJ, et al
    Transcriptomic profiling of radiation-resistant or -sensitive human colorectal cancer cells: Acute effects of a single X-radiation dose.
    Int J Oncol. 2007;30:1369-80.
    PubMed     Related articles    Abstract available
    
    
    
39. RICHIE JP JR , Komninou D, Albino AP
    Induction of colon tumorigenesis by glutathione depletion in p53-knock-out mice.
    Int J Oncol. 2007;30:1539-43.
    PubMed     Related articles    Abstract available
    
    
    
40. SZEPESHAZI K , Schally AV, Halmos G
    LH-RH receptors in human colorectal cancers: unexpected molecular targets for experimental therapy.
    Int J Oncol. 2007;30:1485-92.
    PubMed     Related articles    Abstract available
    
    
    May 2007
41. RICHARD CL , Blay J
    Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner.
    Int J Oncol. 2007;30:1215-22.
    PubMed     Related articles    Abstract available
    
    
    
42. CHEN Y , Lin P, Qiu S, Peng XX, et al
    Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection.
    Int J Oncol. 2007;30:1137-44.
    PubMed     Related articles    Abstract available
    
    
    
43. VENDRELL E , Ribas M, Valls J, Sole X, et al
    Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients.
    Int J Oncol. 2007;30:1099-107.
    PubMed     Related articles    Abstract available
    
    
    March 2007
44. NEILS DM , Virgo KS, Longo WE, Ode K, et al
    Geographic variation in follow-up after rectal cancer surgery.
    Int J Oncol. 2007;30:735-42.
    PubMed     Related articles    Abstract available
    
    
    February 2007
45. LANKESTER KJ , Maxwell RJ, Pedley RB, Dearling JL, et al
    Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, 131I-A5B7, even at doses that are sub-optimal for vascular shut-down.
    Int J Oncol. 2007;30:453-60.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: